This study has been terminated.
( Considered not necessary to continue with this trial; recommended dose was reached in other phase I trials )
Responsible Party: PharmaMar USA Inc ( PharmaMar USA Inc )
Study ID Numbers: PM104-A-002-05
Study First Received: August 1, 2006
Last Updated: April 20, 2009